Transarterial Chemoembolization Before Liver Transplantation in 60 Patients With Hepatocellular Carcinoma

Transplantation Proceedings

Volumn 39, Issue 2, 2007, Pages 537-539

  Otto, G ^a   Heise, M ^a   Moench, C ^a   Herber, S ^a   Bittinger, F ^b   Schuchmann, M ^c   Hoppe Lotichius, M ^a   Pitton, M ^a  

^a Department of Transplantation and Hepatobiliary Surgery ^*  (Germany)

^b Institute of Pathology   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IODINATED POPPYSEED OIL; MITOMYCIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL PROTOCOL; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; DISEASE-FREE SURVIVAL; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; PATIENT SELECTION; PREOPERATIVE CARE; RECURRENCE; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 33847758249     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.12.007     Document Type: Article

References (10)

1. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinoman in patients with cirrhosis. N Engl J Med 334 (1996) 693
2. Decaens T., Roudot-Thoraval F., Bresson-Hadni S., et al. Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl 11 (2005) 767
3. Majno P.E., Adam R., Bismuth H., et al. Influence of preoperative transarterial lipiodol chemoembolization of resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 226 (1997) 688
4. Roayaie S., Frischer J.S., Emre S.H., et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 235 (2002) 533
5. Otto G., Herber S., Heise M., et al. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl 12 (2006) 1260
6. Therasse P., Arbuck S.G., Eisenhauer E.A., et al., European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. New guideline to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92 (2000) 205
7. Yao F.Y., Kinkhabwala M., LaBerge J.M., et al. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant 5 (2005) 795
8. Marsh J.W., Finkelstein S.D., Demetris A.J., et al. Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determing recurrence-free survival. Liver Transpl 9 (2003) 664
9. Mise K., Tashiro S., Yogita S., et al. Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis. Clin Cancer Res 4 (1998) 1475
10. Fiorentino M.F., Altimari A., Ravaioli M., et al. Predictive value of biological markers for hepatocellular carcinoma patients treated with orthotipic liver transplantation. Clin Cancer Res 10 (2004) 1789